Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.

Watson, A J; Gimenez, L F; Cotton, S; Walser, M; Spivak, J L

Watson, A J; Gimenez, L F; Cotton, S; Walser, M; Spivak, J L.

Affiliation

Watson AJ; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Am J Med ; 89(4): 432-5, 1990 Oct.

Article in En | MEDLINE | ID: mdl-2220877

Subject(s)

Anemia/drug therapy; Erythropoietin/therapeutic use; Kidney Failure, Chronic/complications; Adult; Aged; Anemia/blood; Double-Blind Method; Erythropoietin/administration & dosage; Female; Hematocrit; Humans; Injections, Subcutaneous; Kidney Failure, Chronic/blood; Male; Middle Aged; Placebos; Random Allocation; Recombinant Proteins

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Erythropoietin / Anemia / Kidney Failure, Chronic Type of study: Clinical_trials Language: En Journal: Am J Med Year: 1990 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Erythropoietin / Anemia / Kidney Failure, Chronic Type of study: Clinical_trials Language: En Journal: Am J Med Year: 1990 Type: Article